Christopher R. Morse, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Esophagectomy | 20 | 2022 | 482 | 6.060 |
Why?
|
| Esophageal Neoplasms | 14 | 2021 | 1676 | 3.090 |
Why?
|
| Fundoplication | 4 | 2020 | 144 | 0.780 |
Why?
|
| Tracheoesophageal Fistula | 2 | 2020 | 130 | 0.740 |
Why?
|
| Jejunostomy | 1 | 2019 | 61 | 0.660 |
Why?
|
| Thoracic Surgery, Video-Assisted | 3 | 2015 | 296 | 0.620 |
Why?
|
| Trachea | 3 | 2020 | 1095 | 0.600 |
Why?
|
| Thoracic Surgical Procedures | 2 | 2019 | 350 | 0.560 |
Why?
|
| Thoracic Surgery | 2 | 2022 | 727 | 0.550 |
Why?
|
| Papain | 1 | 2015 | 64 | 0.510 |
Why?
|
| Costs and Cost Analysis | 1 | 2021 | 1669 | 0.490 |
Why?
|
| Esophageal Stenosis | 2 | 2015 | 197 | 0.470 |
Why?
|
| Laparoscopy | 4 | 2020 | 2056 | 0.460 |
Why?
|
| Postoperative Complications | 11 | 2021 | 15881 | 0.460 |
Why?
|
| Bronchial Fistula | 2 | 2016 | 83 | 0.450 |
Why?
|
| Gastroesophageal Reflux | 2 | 2019 | 835 | 0.440 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 804 | 0.430 |
Why?
|
| Peptide Hydrolases | 1 | 2015 | 610 | 0.410 |
Why?
|
| Meat | 1 | 2015 | 588 | 0.400 |
Why?
|
| Learning Curve | 1 | 2014 | 232 | 0.390 |
Why?
|
| Tracheal Diseases | 1 | 2012 | 118 | 0.390 |
Why?
|
| Neoadjuvant Therapy | 4 | 2020 | 2909 | 0.390 |
Why?
|
| Foreign Bodies | 1 | 2015 | 403 | 0.370 |
Why?
|
| Lymphatic Diseases | 1 | 2012 | 319 | 0.370 |
Why?
|
| Lymph Nodes | 1 | 2022 | 3471 | 0.360 |
Why?
|
| Hypopharynx | 1 | 2010 | 53 | 0.350 |
Why?
|
| Adenocarcinoma | 3 | 2019 | 6406 | 0.340 |
Why?
|
| Deglutition Disorders | 4 | 2020 | 641 | 0.330 |
Why?
|
| Esophagoscopy | 2 | 2011 | 398 | 0.330 |
Why?
|
| Esophageal Fistula | 1 | 2009 | 60 | 0.320 |
Why?
|
| Diaphragm | 1 | 2010 | 359 | 0.310 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2009 | 244 | 0.300 |
Why?
|
| Pneumonectomy | 5 | 2015 | 1158 | 0.300 |
Why?
|
| Thymus Gland | 1 | 2012 | 1266 | 0.290 |
Why?
|
| Anastomosis, Surgical | 5 | 2020 | 993 | 0.290 |
Why?
|
| Zenker Diverticulum | 1 | 2007 | 28 | 0.280 |
Why?
|
| Liposarcoma | 1 | 2010 | 289 | 0.280 |
Why?
|
| Mediastinal Neoplasms | 1 | 2010 | 403 | 0.280 |
Why?
|
| Bronchoscopy | 4 | 2021 | 913 | 0.270 |
Why?
|
| Surgical Stapling | 1 | 2007 | 100 | 0.270 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 2412 | 0.260 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2006 | 43 | 0.260 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2022 | 520 | 0.260 |
Why?
|
| Spinal Neoplasms | 2 | 2022 | 716 | 0.230 |
Why?
|
| Gastroplasty | 2 | 2019 | 159 | 0.230 |
Why?
|
| Aorta, Thoracic | 1 | 2010 | 1112 | 0.220 |
Why?
|
| Retrospective Studies | 20 | 2022 | 81801 | 0.200 |
Why?
|
| Internship and Residency | 2 | 2019 | 5949 | 0.200 |
Why?
|
| Esophageal Perforation | 1 | 2022 | 65 | 0.190 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2019 | 9433 | 0.190 |
Why?
|
| Male | 33 | 2022 | 364902 | 0.180 |
Why?
|
| Collagen | 1 | 2009 | 2646 | 0.180 |
Why?
|
| Biocompatible Materials | 1 | 2009 | 1704 | 0.180 |
Why?
|
| Aged | 22 | 2022 | 171562 | 0.180 |
Why?
|
| Middle Aged | 24 | 2021 | 223491 | 0.170 |
Why?
|
| Humans | 47 | 2022 | 768393 | 0.170 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2015 | 4069 | 0.170 |
Why?
|
| Defensive Medicine | 1 | 2019 | 47 | 0.160 |
Why?
|
| Chondrosarcoma | 1 | 2022 | 306 | 0.160 |
Why?
|
| Esophageal Achalasia | 1 | 2020 | 98 | 0.160 |
Why?
|
| Obesity | 2 | 2020 | 13084 | 0.160 |
Why?
|
| Neoplasm Staging | 5 | 2019 | 11254 | 0.160 |
Why?
|
| Intraoperative Period | 1 | 2019 | 513 | 0.150 |
Why?
|
| Tomography, Optical Coherence | 2 | 2022 | 2957 | 0.150 |
Why?
|
| Professional Autonomy | 1 | 2019 | 172 | 0.150 |
Why?
|
| Diverticulum, Esophageal | 1 | 2017 | 14 | 0.150 |
Why?
|
| Stents | 4 | 2022 | 3201 | 0.150 |
Why?
|
| Female | 28 | 2022 | 397089 | 0.140 |
Why?
|
| Chordoma | 1 | 2020 | 349 | 0.140 |
Why?
|
| Treatment Outcome | 13 | 2022 | 65379 | 0.140 |
Why?
|
| Lymph Node Excision | 2 | 2020 | 1274 | 0.140 |
Why?
|
| Reoperation | 3 | 2019 | 4341 | 0.130 |
Why?
|
| Bronchi | 1 | 2020 | 849 | 0.130 |
Why?
|
| Free Tissue Flaps | 1 | 2020 | 337 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 2 | 2015 | 3633 | 0.130 |
Why?
|
| Thoracotomy | 1 | 2017 | 374 | 0.130 |
Why?
|
| Esophagus | 3 | 2011 | 1042 | 0.120 |
Why?
|
| Bone Transplantation | 1 | 2020 | 925 | 0.120 |
Why?
|
| Disease-Free Survival | 3 | 2015 | 6856 | 0.120 |
Why?
|
| Gastric Emptying | 2 | 2021 | 246 | 0.120 |
Why?
|
| Proton Pump Inhibitors | 1 | 2019 | 553 | 0.110 |
Why?
|
| Databases, Factual | 3 | 2022 | 8075 | 0.110 |
Why?
|
| Morbidity | 1 | 2019 | 1758 | 0.110 |
Why?
|
| Clinical Competence | 2 | 2019 | 4848 | 0.110 |
Why?
|
| Stomach | 2 | 2021 | 703 | 0.100 |
Why?
|
| Operating Rooms | 1 | 2019 | 799 | 0.100 |
Why?
|
| Benchmarking | 1 | 2019 | 1058 | 0.100 |
Why?
|
| Diagnosis, Differential | 3 | 2012 | 13020 | 0.100 |
Why?
|
| Bioprosthesis | 1 | 2016 | 592 | 0.100 |
Why?
|
| Hospitals, General | 2 | 2017 | 807 | 0.100 |
Why?
|
| Thymectomy | 1 | 2012 | 200 | 0.100 |
Why?
|
| Sternotomy | 1 | 2012 | 132 | 0.100 |
Why?
|
| Survival Analysis | 2 | 2015 | 10117 | 0.090 |
Why?
|
| Education, Medical, Continuing | 2 | 2017 | 829 | 0.090 |
Why?
|
| Gastric Outlet Obstruction | 1 | 2011 | 55 | 0.090 |
Why?
|
| Lumbar Vertebrae | 1 | 2020 | 1885 | 0.090 |
Why?
|
| Pylorus | 1 | 2011 | 86 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12092 | 0.090 |
Why?
|
| Aged, 80 and over | 10 | 2019 | 59686 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2022 | 3960 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2019 | 41795 | 0.090 |
Why?
|
| Adult | 15 | 2022 | 223640 | 0.090 |
Why?
|
| Pleurodesis | 1 | 2010 | 49 | 0.080 |
Why?
|
| Syncope | 1 | 2012 | 430 | 0.080 |
Why?
|
| Hyperhidrosis | 1 | 2009 | 34 | 0.080 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 1309 | 0.080 |
Why?
|
| Sympathectomy | 1 | 2009 | 72 | 0.080 |
Why?
|
| Thoracoscopy | 1 | 2009 | 186 | 0.080 |
Why?
|
| Aorta | 1 | 2016 | 2046 | 0.080 |
Why?
|
| Pneumonia, Aspiration | 1 | 2009 | 145 | 0.080 |
Why?
|
| Esophagoplasty | 1 | 2008 | 48 | 0.080 |
Why?
|
| Preoperative Period | 1 | 2010 | 564 | 0.080 |
Why?
|
| Length of Stay | 2 | 2012 | 6519 | 0.070 |
Why?
|
| Retreatment | 1 | 2009 | 600 | 0.070 |
Why?
|
| Esophageal Sphincter, Upper | 1 | 2007 | 11 | 0.070 |
Why?
|
| Lung Neoplasms | 4 | 2015 | 13576 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 6541 | 0.070 |
Why?
|
| Barrett Esophagus | 1 | 2011 | 494 | 0.070 |
Why?
|
| Blood Loss, Surgical | 1 | 2011 | 643 | 0.070 |
Why?
|
| Esophageal Diseases | 1 | 2008 | 168 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6241 | 0.070 |
Why?
|
| Prognosis | 4 | 2021 | 30022 | 0.070 |
Why?
|
| Pneumonia, Bacterial | 1 | 2009 | 319 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 36849 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2862 | 0.070 |
Why?
|
| Logistic Models | 1 | 2020 | 13323 | 0.060 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2009 | 664 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 3438 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2015 | 5422 | 0.060 |
Why?
|
| Surgical Flaps | 2 | 2016 | 1682 | 0.060 |
Why?
|
| Postoperative Period | 1 | 2010 | 1830 | 0.060 |
Why?
|
| Catheterization | 1 | 2011 | 1431 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 20765 | 0.060 |
Why?
|
| Perioperative Care | 1 | 2012 | 1045 | 0.060 |
Why?
|
| Time Factors | 4 | 2021 | 40272 | 0.060 |
Why?
|
| Defibrillators, Implantable | 1 | 2012 | 1498 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2020 | 13052 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2012 | 2258 | 0.050 |
Why?
|
| Manometry | 2 | 2017 | 459 | 0.050 |
Why?
|
| Ethanol | 3 | 1998 | 1332 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12558 | 0.050 |
Why?
|
| Young Adult | 5 | 2015 | 60049 | 0.050 |
Why?
|
| Fatty Acids | 3 | 1998 | 1815 | 0.050 |
Why?
|
| Sarcoma | 1 | 2011 | 1807 | 0.040 |
Why?
|
| Carcinoma | 1 | 2011 | 2341 | 0.040 |
Why?
|
| Ribs | 1 | 2022 | 259 | 0.040 |
Why?
|
| Colon | 1 | 2008 | 1805 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2021 | 54920 | 0.040 |
Why?
|
| Quality of Life | 2 | 2019 | 13503 | 0.040 |
Why?
|
| Risk Factors | 3 | 2022 | 74962 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2021 | 24318 | 0.040 |
Why?
|
| Equipment Design | 1 | 2007 | 3529 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15939 | 0.040 |
Why?
|
| Boston | 1 | 2012 | 9371 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2012 | 5367 | 0.040 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 3681 | 0.040 |
Why?
|
| Acyltransferases | 2 | 1998 | 306 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2010 | 6001 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2022 | 2127 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 39407 | 0.030 |
Why?
|
| Spine | 1 | 2022 | 1141 | 0.030 |
Why?
|
| Survival Rate | 3 | 2015 | 12870 | 0.030 |
Why?
|
| Debridement | 1 | 2016 | 492 | 0.030 |
Why?
|
| Minnesota | 1 | 2011 | 338 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2011 | 615 | 0.020 |
Why?
|
| Cocaine | 1 | 1995 | 960 | 0.020 |
Why?
|
| Pressure | 1 | 2011 | 1172 | 0.020 |
Why?
|
| Esophagitis, Peptic | 1 | 2008 | 77 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2015 | 2925 | 0.020 |
Why?
|
| Vital Capacity | 1 | 2010 | 984 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2011 | 2663 | 0.020 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2011 | 887 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 2010 | 1820 | 0.010 |
Why?
|
| Video Recording | 1 | 2009 | 974 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 1996 | 4049 | 0.010 |
Why?
|
| Lung | 1 | 2022 | 10089 | 0.010 |
Why?
|
| Models, Animal | 1 | 2009 | 2124 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 4921 | 0.010 |
Why?
|
| Swine | 1 | 2009 | 5994 | 0.010 |
Why?
|
| Brefeldin A | 1 | 1998 | 68 | 0.010 |
Why?
|
| Acyl Coenzyme A | 1 | 1998 | 56 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2009 | 5313 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1998 | 174 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1998 | 323 | 0.010 |
Why?
|
| Child | 1 | 2006 | 80891 | 0.010 |
Why?
|
| Esterification | 1 | 1996 | 39 | 0.010 |
Why?
|
| Comorbidity | 1 | 2011 | 10588 | 0.010 |
Why?
|
| Culture Media | 1 | 1998 | 898 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18471 | 0.010 |
Why?
|
| Esters | 1 | 1996 | 212 | 0.010 |
Why?
|
| Albumins | 1 | 1998 | 577 | 0.010 |
Why?
|
| Cytosol | 1 | 1998 | 886 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2008 | 4505 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 1996 | 436 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1998 | 1753 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 1998 | 682 | 0.010 |
Why?
|
| Substance Abuse Detection | 1 | 1996 | 300 | 0.010 |
Why?
|
| Lipoproteins | 1 | 1998 | 880 | 0.010 |
Why?
|
| Smoking | 1 | 2010 | 9111 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 21544 | 0.010 |
Why?
|
| Adolescent | 2 | 2011 | 89184 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1995 | 2299 | 0.010 |
Why?
|
| United States | 1 | 2017 | 73150 | 0.010 |
Why?
|
| Cell Line | 1 | 1998 | 15597 | 0.000 |
Why?
|
| Liver | 1 | 1998 | 7574 | 0.000 |
Why?
|
| Animals | 1 | 2009 | 169337 | 0.000 |
Why?
|